Paying users zone. Data is covered by hidden.

  • Get to Allergan PLC for $15.99, or

  • get to whole website for at least 3 months from $49.99.

Microsoft Excel LibreOffice Calc

Allergan PLC (AGN)

Long-term Debt and Solvency Analysis

Difficulty: Beginner

  • Annual Data
  • Quarterly Data

    • Solvency ratios also known as long-term debt ratios measure a company's ability to meet long-term obligations.

    Ratios (Summary)

    Allergan PLC, debt and solvency ratios

    Microsoft Excel LibreOffice Calc
    Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
    Debt to equity hidden hidden hidden hidden hidden
    Debt to capital hidden hidden hidden hidden hidden
    Interest coverage hidden hidden hidden hidden hidden

    Source: Based on data from Allergan PLC Annual Reports

    Ratio Description The company
    Debt-to-equity ratio A solvency ratio calculated as total debt divided by total shareholders' equity. Allergan PLC's debt-to-equity ratio improved from 2015 to 2016 and from 2016 to 2017.
    Debt-to-capital ratio A solvency ratio calculated as total debt divided by total debt plus shareholders' equity. Allergan PLC's debt-to-capital ratio improved from 2015 to 2016 and from 2016 to 2017.
    Interest coverage ratio A solvency ratio calculated as EBIT divided by interest payments. Allergan PLC's interest coverage ratio improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

    Debt to Equity

    Allergan PLC, debt to equity calculation, comparison to benchmarks

    Microsoft Excel LibreOffice Calc
    Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
    Selected Financial Data (USD $ in thousands)
    Current portion of long-term debt and capital leases hidden hidden hidden hidden hidden
    Long-term debt and capital leases, excluding current portion hidden hidden hidden hidden hidden
    Total debt hidden hidden hidden hidden hidden
    Shareholders' equity hidden hidden hidden hidden hidden
    Ratio
    Debt to equity1 hidden hidden hidden hidden hidden
    Benchmarks
    Debt to Equity, Competitors
    Abbott Laboratories hidden hidden hidden hidden hidden
    AbbVie Inc. hidden hidden hidden hidden hidden
    Amgen Inc. hidden hidden hidden hidden hidden
    Biogen Inc. hidden hidden hidden hidden hidden
    Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
    Celgene Corp. hidden hidden hidden hidden hidden
    Eli Lilly & Co. hidden hidden hidden hidden hidden
    Gilead Sciences Inc. hidden hidden hidden hidden hidden
    Johnson & Johnson hidden hidden hidden hidden hidden
    Merck & Co. Inc. hidden hidden hidden hidden hidden
    Pfizer Inc. hidden hidden hidden hidden hidden
    Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
    Debt to Equity, Sector
    Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
    Debt to Equity, Industry
    Health Care hidden hidden hidden hidden hidden

    Source: Based on data from Allergan PLC Annual Reports

    2017 Calculations

    1 Debt to equity = Total debt ÷ Shareholders' equity
    = hidden ÷ hidden = hidden

    Ratio Description The company
    Debt-to-equity ratio A solvency ratio calculated as total debt divided by total shareholders' equity. Allergan PLC's debt-to-equity ratio improved from 2015 to 2016 and from 2016 to 2017.

    Debt to Capital

    Allergan PLC, debt to capital calculation, comparison to benchmarks

    Microsoft Excel LibreOffice Calc
    Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
    Selected Financial Data (USD $ in thousands)
    Current portion of long-term debt and capital leases hidden hidden hidden hidden hidden
    Long-term debt and capital leases, excluding current portion hidden hidden hidden hidden hidden
    Total debt hidden hidden hidden hidden hidden
    Shareholders' equity hidden hidden hidden hidden hidden
    Total capital hidden hidden hidden hidden hidden
    Ratio
    Debt to capital1 hidden hidden hidden hidden hidden
    Benchmarks
    Debt to Capital, Competitors
    Abbott Laboratories hidden hidden hidden hidden hidden
    AbbVie Inc. hidden hidden hidden hidden hidden
    Amgen Inc. hidden hidden hidden hidden hidden
    Biogen Inc. hidden hidden hidden hidden hidden
    Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
    Celgene Corp. hidden hidden hidden hidden hidden
    Eli Lilly & Co. hidden hidden hidden hidden hidden
    Gilead Sciences Inc. hidden hidden hidden hidden hidden
    Johnson & Johnson hidden hidden hidden hidden hidden
    Merck & Co. Inc. hidden hidden hidden hidden hidden
    Pfizer Inc. hidden hidden hidden hidden hidden
    Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
    Debt to Capital, Sector
    Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
    Debt to Capital, Industry
    Health Care hidden hidden hidden hidden hidden

    Source: Based on data from Allergan PLC Annual Reports

    2017 Calculations

    1 Debt to capital = Total debt ÷ Total capital
    = hidden ÷ hidden = hidden

    Ratio Description The company
    Debt-to-capital ratio A solvency ratio calculated as total debt divided by total debt plus shareholders' equity. Allergan PLC's debt-to-capital ratio improved from 2015 to 2016 and from 2016 to 2017.

    Interest Coverage

    Allergan PLC, interest coverage calculation, comparison to benchmarks

    Microsoft Excel LibreOffice Calc
    Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
    Selected Financial Data (USD $ in thousands)
    Net income (loss) attributable to shareholders hidden hidden hidden hidden hidden
    Add: Net income attributable to noncontrolling interest hidden hidden hidden hidden hidden
    Less: Income (loss) from discontinued operations, net of tax hidden hidden hidden hidden hidden
    Add: Income tax expense hidden hidden hidden hidden hidden
    Add: Interest expense hidden hidden hidden hidden hidden
    Earnings before interest and tax (EBIT) hidden hidden hidden hidden hidden
    Ratio
    Interest coverage1 hidden hidden hidden hidden hidden
    Benchmarks
    Interest Coverage, Competitors
    Abbott Laboratories hidden hidden hidden hidden hidden
    AbbVie Inc. hidden hidden hidden hidden hidden
    Amgen Inc. hidden hidden hidden hidden hidden
    Biogen Inc. hidden hidden hidden hidden hidden
    Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
    Celgene Corp. hidden hidden hidden hidden hidden
    Eli Lilly & Co. hidden hidden hidden hidden hidden
    Gilead Sciences Inc. hidden hidden hidden hidden hidden
    Johnson & Johnson hidden hidden hidden hidden hidden
    Merck & Co. Inc. hidden hidden hidden hidden hidden
    Pfizer Inc. hidden hidden hidden hidden hidden
    Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
    Interest Coverage, Sector
    Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
    Interest Coverage, Industry
    Health Care hidden hidden hidden hidden hidden

    Source: Based on data from Allergan PLC Annual Reports

    2017 Calculations

    1 Interest coverage = EBIT ÷ Interest expense
    = hidden ÷ hidden = hidden

    Ratio Description The company
    Interest coverage ratio A solvency ratio calculated as EBIT divided by interest payments. Allergan PLC's interest coverage ratio improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.